Canadian Association of Radiologists Journal
Volume 61, Issue 4 , Pages 217-222 , October 2010

Ablative Technologies in the Management of Patients with Primary and Secondary Liver Cancer: An Overview

  • Nasir A. Khan, HBSc

      Affiliations

    • Undergraduate Medical Education, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Mark O. Baerlocher, MD

      Affiliations

    • Department of Medical Imaging, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    • ,
  • Richard J.T. Owen, MD

      Affiliations

    • Department of Radiology and Diagnostic Imaging, Faculty of Medicine, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Stephen Ho, MD

      Affiliations

    • Department of Radiology, Interventional Radiology Section, Vancouver General Hospital, Vancouver, British Columbia, Canada
    • ,
  • John R. Kachura, MD

      Affiliations

    • Department of Medical Imaging, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
    • Department of Medical Imaging, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
    • ,
  • Stephen T. Kee, MD

      Affiliations

    • Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA
    • ,
  • Dave M. Liu, MD

      Affiliations

    • Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, CA
    • Department of Radiology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
    • Department of Radiology, Interventional Radiology Section, Vancouver General Hospital, Vancouver, British Columbia, Canada
    • Corresponding Author InformationAddress for correspondence: Dave M. Liu, MD, Department of Radiology, Vancouver General Hospital, 855 West 12th Avenue, Vancouver, British Columbia V5Z 1M9, Canada.

References 

  1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750
  2. Mazzaferro V, Chun YS, Poon RT, et al. Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol. 2008;15:1001–1007
  3. Sutherland LM, Williams J, Padbury R, et al. Radiofrequency ablation of liver tumors: a systemic review. Arch Surg. 2006;141:181–190
  4. Pawlik TM, Choti MA. Surgical therapy for colorectal metastasis to the liver. J Gastrointest Surg. 2007;11:1057–1077
  5. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239:818–825
  6. Tabernero J, Van Cutsem E, Díaz-Rubio E. Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2007;25:5225–5232
  7. Moehler M, Sprinzl MF, Abdelfattah M, et al. Capecitabine and irinotecan with and without bevacizumab for advanced colorectal cancer patients. World J Gastroenterol. 2009;15:449–456
  8. Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol. 2004;39:689–697
  9. Siperstein AE, Berber E, Ballem N, et al. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007;246:559–565
  10. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology. 1995;197:101–108
  11. Shiina S, Tagawa K, Niwa Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol. 1993;160:1023–1028
  12. Amin Z, Bown SG, Lees WR. Local treatment of colorectal liver metastasis: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol. 1993;48:166–171
  13. Giovannini M. Percutaneous alcohol ablation for liver metastasis. Semin Oncol. 2002;29:192–195
  14. Clark TW. Chemical ablation of Liver cancer. Tech Vasc Interv Radiol. 2007;10:58–63
  15. Di Stasi M, Buscarini L, Livraghi T, et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multi-center survey of evaluation practices and complication rates. Scand J Gastroenterol. 1997;32:1168–1173
  16. Gelczer RK, Charboneau JW, Hussain S, et al. Complications of percutaneous ethanol ablation. J Ultrasound Med. 1998;17:531–533
  17. Ohnishi K, Nomura F, Ito S, et al. Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology. 1996;23:994–1002
  18. Rhim H, Goldberg SN, Dodd GD, et al. Essential techniques for more successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics. 2001;21:17–35
  19. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancies: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol. 2000;174:323–331
  20. Lencioni R, Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol. 2007;10:38–46
  21. Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastasis: percutaneous radiofrequency ablation with cooled-tip electrodes. Radiology. 1997;205:367–373
  22. Eisele RM, Neuhaus P, Schumacher G. Radiofrequency ablation of liver tumors using a novel bipolar device. J Laparoendosc Adv Surg Tech A. 2008;18:857–863
  23. Garcea G, Llyod TD, Aylott C, et al. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumors. Eur J Cancer. 2003;39:2150–2164
  24. Gannon CJ, Curley SA. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors. Semin Radiat Oncol. 2005;15:265–272
  25. Simon CJ, Dupuy DE, Iannitti DA, et al. Intraoperative triple antenna hepatic microwave ablation. AJR Am J Roentgenol. 2006;187:w333–w340
  26. Refer to product monograph.
  27. Hinshaw JL, Lee FT. Cryoablation for liver cancer. Tech Vasc Interv Radiol. 2007;10:47–57
  28. Wang H, Littrup PJ, Duan Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289–298
  29. Miller L, Leor J, Rubinsky B. Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat. 2005;4:699–705
  30. Lee EW, Loh CT, Kee ST. Imaging guided percutaneous irreversible electroporation: ultrasound and immunohistological correlation. Technol Cancer Res Treat. 2007;6:287–294
  31. Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality—clinical implications. Technol Cancer Res Treat. 2007;6:37–48
  32. Covey AM, Maluccio MA, Schubert J, et al. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy. Cancer. 2006;106:2181–2189
  33. Meric F, Patt YZ, Curley SA, et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol. 2000;7:490–495
  34. McEntee GP, Nagorney DM, Kvols LK, et al. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery. 1990;108:1091–1096
  35. Lai EC, Tang CN, Ha JP, et al. Cytoreductive surgery in multidisciplinary treatment of advanced hepatocellular carcinoma. ANZ J Surg. 2008;78:504–507
  36. Hamy A, Bennouna J, Heymann MF, et al. Repeat hepatectomy for colorectal liver metastases. Int Surg. 2005;90:189–197
  37. Morise Z, Sugioka A, Fujita J, et al. Does repeated surgery improve the prognosis of colorectal liver metastases?. J Gastrointest Surg. 2006;10:6–11
  38. Meric F, Patt YZ, Curley SA, et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol. 2000;7:490–495
  39. Carpizo DR, Are C, Jarnagin W, et al. Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol. 2009;16:2138–2146
  40. Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19:1206–1213
  41. Clark OH, Benson AB, Berlin JD, et al. NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. J Natl Compr Canc Netw. 2009;7:712–747

PII: S0846-5371(09)00277-0

doi: 10.1016/j.carj.2009.12.009

Canadian Association of Radiologists Journal
Volume 61, Issue 4 , Pages 217-222 , October 2010

Article Tools

* Image Usage & Resolution